Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.
Sallah S, Husain A, Nguyen NP
Blood Coagul Fibrinolysis 2004;15(7):577-582.
Review by M. Aldouri
The use of recombinant factor VIIa in the treatment of bleeding disorders.
Roberts HR, Monroe DM, White GC
Blood 2004 Aug 24 [Epub ahead of print]
Review by
Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A, Misgav M, Kluger Y, et al.
Vox Sang 2004;87:34-40.
Review by
A novel hemostatic agent: the potential role of recombinant activated factor VII (RFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth 2002;49(10):S21-S26.
Review by Aldouri M
Small-volume resuscitation with HBOC-201: effects on cardiovascular parameters and brain tissue oxygen tension in an out-of-hospital model of hemorrhage in swine.
Lee SK, Morabito D, Hemphill JC, et al.
Acad Emerg Med 2002;9(10):969-976.
Review by
HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury.
Katz LM, Manning JE, McCurdy SL, et al.
Resuscitation 2002;54(1):77-87.
Review by Van der Linden P
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Sajdak S, Moszynski R, Opala T
Eur J Gynaecol Oncol 2002;23(4):325-326.
Review by
Treatment of critical bleeding in the future intensive care unit. [Editorial]
Goodnough LT
Intensive Care Med 2002;28(Suppl 2):S221.
Review by Aldouri M
The use of recombinant factor VIIa in a Jehovah’s Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
Waddington DP, McAuley FT, Hanley JP, Summerfield GP
Br J Haematol 2002;119(1):286-288.
Review by Aldouri M
NovoSeven: mode of action and use in acquired haemophilia.
Von Depka M
Intensive Care Med 2002;28(Suppl 2):S222-S227.
Review by M. Aldouri
Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Kessler C
Intensive Care Med 2002;28(Suppl 2):S228-S234.
Review by Aldouri M
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA, Holcomb JB, Hedner U, Brundage SI, Macaitis JM, Hoots K
J Trauma 2002;53(2):252-257.
Review by Aldouri M
Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report.
Gerlach R, Marquardt G, Wissing H, et al.
J Neurosurg 2002;96(5):946-948.
Review by
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.
Toor AA, Slungaard A, Hedner U, Weisdorf DJ, Key NS
Bone Marrow Transplant 2002;29(5):403-408.
Review by Aldouri M
Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial.
A useful study (notwithstanding power) and review of current practices. – F. Regan and M. Contreras.
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659